Th17-associated cytokines, CRP fail as biomarkers for ustekinumab success in PsAMay 17, 2019Psoriatic Arthritis
VA system lags in getting DMARDs to veterans with inflammatory arthritisMay 14, 2019Ankylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Etanercept biosimilar SB4 a cost-effective alternative for psoriasis, PsAMay 14, 2019Psoriatic Arthritis
Arthritis joint pain, inactivity vary greatly across U.S.May 3, 2019Rheumatoid ArthritisOsteoarthritisGoutLupus & Connective Tissue DiseasesPainPsoriatic ArthritisSpondyloarthropathies
PsA patients had durable responses after 1 year of IV golimumab treatmentApril 30, 2019Psoriatic Arthritis
Positive psoriatic arthritis screens occur often in psoriasis patientsApril 30, 2019Psoriatic Arthritis
FDA approves new etanercept biosimilar, EticovoApril 26, 2019Ankylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatrics
FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasisApril 23, 2019Psoriatic Arthritis
TNF-alpha, adiponectin potential biomarkers for PsA, psoriasis differentiationApril 14, 2019Psoriatic Arthritis
AFib, CVD risks similar after ustekinumab and TNF inhibitors in psoriatic patientsApril 9, 2019Psoriatic Arthritis
Four biomarkers could distinguish psoriatic arthritis from osteoarthritisMarch 28, 2019Psoriatic ArthritisOsteoarthritis
